Department of Criminology and Criminal Justice, Western Carolina University, Cullowhee, NC 28723, USA.
Subst Use Misuse. 2012 Oct;47(12):1328-38. doi: 10.3109/10826084.2012.714039. Epub 2012 Aug 27.
The current study used an automated version of the substance use disorder diagnostic schedule-IV (SUDDS-IV) to assess DSM-IV (fourth edition of the Diagnostic and statistical manual of mental disorders) and two sets of proposed DSM-5 (fifth edition of the Diagnostic and statistical manual of mental disorders) cannabis use disorder criteria among adult prison inmates in the Minnesota Department of Corrections state prison system from 2000 to 2003. Initially proposed DSM-5 criteria had only two diagnostic designations (moderate and severe). A subsequent revision added a mild designation and required a greater number of positive findings for the severe diagnosis. The sample was composed of 7,672 (89.6% male) inmates. Inmates with no DSM-IV diagnoses and most who currently received a cannabis dependence diagnosis according to the DSM-IV guidelines will fit into corresponding DSM-5 categories (i.e., no diagnosis and severe cannabis use disorder, respectively). Some diagnostic criteria, in addition to those proposed for the DSM-5, emerged as cardinal indicators of moderate cannabis use disorder. The study's limitations are noted.
本研究使用物质使用障碍诊断量表-IV（SUDDS-IV）的自动化版本，评估了明尼苏达州惩教署州立监狱系统中的成年囚犯在 2000 年至 2003 年期间的 DSM-IV（精神障碍诊断和统计手册第四版）和两组拟议的 DSM-5（精神障碍诊断和统计手册第五版）大麻使用障碍标准。最初提出的 DSM-5 标准只有两种诊断指定（中度和重度）。随后的修订增加了轻度指定，并要求严重诊断有更多的阳性发现。该样本由 7672 名（89.6%为男性）囚犯组成。没有 DSM-IV 诊断的囚犯和大多数目前根据 DSM-IV 指南被诊断为大麻依赖的囚犯将归入相应的 DSM-5 类别（即，无诊断和严重大麻使用障碍）。除了为 DSM-5 提出的那些标准外，一些诊断标准也成为中度大麻使用障碍的重要指标。研究的局限性已被指出。
